Header cover image

Taiwanese Pharmaceuticals & Biotech High And Sustainable

Results

2

0 new

Companies in a sound financial shape with a dividend yield of more than 5%.

2 companies

TSH Biopharm

Market Cap: NT$1.9b

Develops and markets pharmaceutical products in Taiwan.

8432

NT$50.30

7D

-0.8%

1Y

3.5%

TTY Biopharm

Market Cap: NT$18.9b

Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan, the United States, and internationally.

4105

NT$76.20

7D

-3.2%

1Y

-0.4%